Ross Andrew Soo Selected Research

Ross Andrew Soo Research Topics

Disease

10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2012
10	Neoplasms (Cancer) 08/2022 - 09/2010
4	Lung Neoplasms (Lung Cancer) 01/2018 - 02/2013
2	Neoplasm Metastasis (Metastasis) 02/2021 - 04/2016
2	Tics (Tic) 01/2016 - 01/2012
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2015 - 02/2013
1	Infections 07/2021
1	Chronic Hepatitis B 07/2021
1	Hepatitis B 07/2021
1	Diarrhea 12/2020
1	Exanthema (Rash) 12/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Nasopharyngeal Carcinoma 10/2020
1	Neutropenia 02/2016
1	Liver Diseases (Liver Disease) 02/2016
1	Disease Progression 01/2016
1	Carcinogenesis 01/2012
1	Stomach Neoplasms (Stomach Cancer) 09/2010

Drug/Important Bio-Agent (IBA)

4	Tyrosine Kinase InhibitorsIBA 10/2023 - 12/2017
4	ErbB Receptors (EGF Receptor)IBA 10/2023 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2010
2	Gefitinib (Iressa)FDA Link 11/2020 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 07/2015
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
1	osimertinibIBA 10/2023
1	TropomyosinIBA 08/2022
1	entrectinibIBA 08/2022
1	larotrectinibIBA 08/2022
1	tyrosine receptor (receptor, tyrosine)IBA 08/2022
1	Phosphotransferases (Kinase)IBA 08/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2021
1	LigandsIBA 07/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2021
1	icotinibIBA 12/2020
1	tepotinibIBA 11/2020
1	Sunitinib (Sutent)FDA Link 10/2020
1	Gemcitabine FDA Link 10/2020
1	Immune Checkpoint InhibitorsIBA 08/2020
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	PanobinostatIBA 01/2018
1	imidazoleacetic acid (IMAC)IBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2016
1	Proton Pump InhibitorsIBA 12/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2016
1	Docetaxel (Taxotere)FDA Link 02/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	locked nucleic acidIBA 01/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2015
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2013
1	Adenosine Monophosphate (AMP)IBA 02/2013
1	Serine (L-Serine)FDA Link 01/2012
1	pyrimidineIBA 01/2012
1	Glycine Dehydrogenase (Decarboxylating)IBA 01/2012
1	EnzymesIBA 01/2012
1	Stem Cell FactorIBA 01/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2012
1	Conditioned Culture MediaIBA 09/2010
1	Proteins (Proteins, Gene)FDA Link 09/2010

Therapy/Procedure

10	Therapeutics 08/2022 - 01/2012
2	Drug Therapy (Chemotherapy) 02/2021 - 10/2020